Rated on Jul 21, 2018
Modified on Aug 24, 2018
The team needs more blockchain experience. Apart from the budget (page 38 of the WP) there should be more business planning numbers. No competitive analysis available// improved after checking the working project and their successful efforts to raise venture capital. I will recheck later again
Rated on Aug 2, 2018
Modified on Dec 6, 2018
There is no business plan about the sensor and his impact on the market.
The team needs more experience on fundraising and blockchain projects.
I dont know how the investor can get roi, the sensor should be a standard on the market to get results.
I love the vision, as sportsman and sports businessman I can understand the potential of DYNO, but vision doesnt assure results.
Rate improved after team response.
Rated on Jul 25, 2018
The innovation is solving a real problem and the analytics collected will be of true value to healthcare providers and insurers
The tokenomics is also well structured and when the business plan is duly executed, the value of tokens will be well supported.
The team is also robust with professionals in relevant fields.
Rated on Jul 24, 2018
Metabolism Analysis based on breathing gases surely has potential. Today's analysis models are much more expensive and need more effort than Dyno.
Although a Blockchain approach is not really needed, this Token might become valuable by leveraging the generated data.
Rated on Jun 14, 2018
As rightly said that "Health is Wealth", I am sure the future is bright for companies venturing into space. An ICO from existing company with existing product line is always beneficial but integrating blockchain data into the line can be challenging. Based on backing from strong team having an entrepreneurial experience and debt free books, i will give this company thumb up but KYC part is missing, which has to be addressed by the team. Token economics has been worked out carefully. Token burn mechanism can reduce the circulating supply post mass adoption and can thus boost token value for investors.
Rated on Jun 14, 2018
Modified on Jun 14, 2018
Dynostics caught my attention for having an existing business and product. After having an interaction with the team I would give them a very good rating based on the following reasons:
1- Dynostics is an existing company with a very useful product and growing sales
2- They have a very interesting B2B revenue model that provides them with a continuous cash flow
3- Their devices collect a unique set of biological markers that can be of interest not only to individuals but also to research institutes and insurance companies
4- By integrating the blockchain, they are giving users the data ownership and a possibility to monetize it
Rated on Jul 30, 2018
VISION: Interesting vision, although niche. There may be privacy issues, particularly in Europe. The ambition to dominate the market is probably strategically correct if it can be achieved. Although I am unsure that the blockchain will ensure that medical researchers get the correct type of high quality data that they need. 3/5
TEAM: A large team covering an extensive set of skills, though could use more than the two advisors listed to carefully navigate some complex issues. 4/5
PRODUCT: The MVP is available and the white paper is particularly clear which is good at this stage. 4/5
This is not an invitation to invest. ICOs are risky and you can lose everything you put in.
We completely align with the GDPR - even more: blockchain gives us the possibility to ensure a users its right to be forgotten as well to automatically implement time frames that are defined within the GDPR of how long private data is allowed to be saved. But even more, our data structure is way ahead of GDPR making the data more secure since personal data, user meta data and user metabolic data are stored separately. So blockchain ensures us to secure a users rights and it is not needed to ensure the quality of the data like you assume - so it will not help medical researches by giving them the quality itself, this is assured thru our device and a user KYC itself, but it will make it possible for the first time to make this kind of data even accessible to medical researchers cause due to privacy issues in Europe and especially in Germany this kind of data never was accessible for them in a broad scale.
Rated on Aug 3, 2018
The team lack blockchain expertise. The hardware, itself, is a good product however the use of blockchain and a token is not mass market. The use case is far too specific for a singular device and is unlikely to gather mass adoption as per the current vision. This means that the number of users of this particular blockchain will have plenty of acquisition probelms considering there are plenty of data exchange and IoT products and other health tracking IoT devices out there.
"The team lack blockchain expertise."
—> The lack of blockchain experience may be an issue that could be looked at closer, but hence this still is quite a young sector the teams that only have highly skilled members are really rare or simply don’t tell the truth. We have two leading software engineers that have proficient experience within the blockchain industry as well as team members and advisory that have very good knowledge and experience, so we do think that this rating is not justified.
"However the use of blockchain and a token is not mass market. The use case is far too specific for a singular device and is unlikely to gather mass adoption as per the current vision."
—> Well, it depends on how you see the market and understand the product. If you think that people that somehow want to change their nutrition habits, life a healthier life style, have weight problems and want to loose weight or have any other problems with nutrition and fitness or just want to start doing sport the right way are all a small niche than you are probably right. From our point of view all those people are within our target group and are one of the biggest target group within the age of 14 to 60 that a product can address and change their lives, so we think that this point could be re-thought.
"…there are plenty of data exchange and IoT products and other health tracking IoT devices"
—> Yes, there are. But first of all none of them is or will be able (in the near future) to produce the analytical data we produce and that is needed on the market and second, we are building the marketplace / profiles open source, so all other IoT / data-producing devices can add their data to our product. But hence we are producing by far the most valuable and sensitive data with our device we definitely think that we should have a saying in who is building the marketplace and how the data of our customers should be secured.
Experts are independently and voluntarily contributing to the community. If no expert has rated the ICO, only ICO analyzer's results are used. Always research before investing as these ratings should not be taken as an investing guide of any kind.
Ratings and ICO analyzer results are being updated (re-calculated) every few hours.